In this respect, a meta-analysis of publicly available breast cancer gene expression data, including those from several published prognostic signatures, revealed that more than 70% of the genes associated with patient survival were correlated with the proliferation pathway, whereas 26% were related to estrogen receptor (ER) signaling and 2% to ERBB2 amplification[4]. This evidence concerns the gene ERBB2 and breast cancer.